Herb-drug interactions and patient counseling

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 1, Issue SUPPL. 1, 2009, Pages 151-161

  Ismail, Mohammad Yaheya Mohammad ^a  

^a Higher College of Technology   (India)

Author keywords

Counseling; Herb drug interaction; Herbal preparation; Herbs

Indexed keywords

ACETYLSALICYLIC ACID; ANGELICA SINENSIS EXTRACT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CARICA PAPAYA EXTRACT; CORTICOSTEROID; CYCLOSPORIN; DIGOXIN; EMODIN; GARLIC EXTRACT; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; ISPAGULA; LITHIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PARTHENOLIDE; PROTEINASE INHIBITOR; RHUBARB EXTRACT; SALVIA MILTIORRHIZA EXTRACT; TANACETUM PARTHENIUM EXTRACT; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALERIAN; WARFARIN; YOHIMBINE;

ALOE; ANTICOAGULANT THERAPY; BLEEDING; BRAIN HEMORRHAGE; CHINESE MEDICINE; CLINICAL PRACTICE; DIARRHEA; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; EPIDURAL HEMATOMA; HERB DRUG INTERACTION; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTENSION; NONHUMAN; PATIENT COUNSELING; PATIENT SAFETY; PHYTOCHEMISTRY; PRESCRIPTION; REVIEW; WORLD HEALTH ORGANIZATION;

EID: 77953413952     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Eisenberg DM, Davis RB, Ettner SL. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998; 280:1569-1575.
2. Kuhn M, Winston D. Herbal Therapy and Supplements: A Scientific and Traditional Approach. Philadelphia, Pa: JB Lippincott; 2001.
3. Smith M. Drug interactions with natural health products/dietary supplements: a survival guide. Paper presented at Complementary and Alternative Medicine: Implications for Clinical Practice and State-of-the-Science Symposia; March 12, 2000; Boston, Mass.
4. Kuhn M. Pharmacotherapeutics: A Nursing Process Approach. Philadelphia, Pa: FA Davis; 1998.
5. Burnham BE. Garlic as a possible risk for postoperative bleeding. Plast Reconstr Surg 1995; 95:213.
6. Rose KD, et al. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic consumption: A case report. Neurosurgery 1990; 26:880-882.
7. Fugh-Berman A, Ernst E. Herb-drug interactions: Review and assessment of report reliability. Br J Clin Pharmacol 2001; 52:587-595.
8. Page RL 2nd, Lawrence JD. Potentiation of warfarin by dong quai. Pharmacotherapy 1999; 19:870-876.
9. Lo ACT, et al. Danggui (Angelica sinensis) affects the pharmacodynamics but not the pharmacokinetics of warfarin in rabbits. Eur J Drug Metab Pharmacokinet 1995; 20:55-60.
10. Shulman A. Toxicological problems of traditional remedies and food supplements. Int J Altern Complement Med 1997; Jan: 9-10.
11. Groenewegen WA, Heptinstall S. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew on human platelet activity in-vitro. J Pharm Pharmacol 1990; 42:553-557.
12. Lumb AB. Effect of dried ginger on human platelet function. Thromb Haemost 1994; 71:110-111.
13. Dorso CR, et al. Chinese food and platelets [letter]. N Engl J Med 1980; 303:756-757.
14. Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother 2000; 34:1478-82.
15. Hu Z, Yang X, Ho PC, Chang SY, Heng PW, Chan E, . Herb-drug interactions: a literature review. Drugs 2005; 65:1239-82.
16. Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2004;57:592-9.
17. Zhou S, Chan E, Pan SQ, Huang M, Lee EJ. Pharmacokinetic interactions of drugs with St. John's wort. J Psychopharmacol 2004; 18:262-76.
18. Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P. St John's wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol 2002; 54: 349-56.
19. Jiang X, Blair EY, McLachlan AJ. Investigation of the effects of herbal medicines on warfarin response in healthy subjects: a population pharmacokinetic pharmacodynamic modeling approach. J Clin Pharm 2006; 46:1370-8.
20. Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2005; 59:425-32.
21. Mohutsky MA, Anderson GD, Miller JW, Elmer GW. Ginkgo biloba : evaluation of CYP2C9 drug interactions in vitro and in vivo. Am J Ther 2006; 13:24-31.
22. Meisel C, Johne A, Roots I. Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen. Atherosclerosis 2003; 167:367.
23. Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther 2002; 27:391-401.
24. Bebbington A, Kulkarni R, Roberts P. Ginkgo biloba : persistent bleeding after total hip arthroplasty caused by herbal self-medication. J Arthroplasty 2005; 20:125-6.
25. Macan H, Uykimpang R, Alconcel M, Takasu J, Razon R, Amagase H, et al. Aged garlic extract may be safe for patients on warfarin therapy. J Nutr 2006; 136(3 suppl):793S-795S.
26. Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial. Ann Intern Med 2004; 141:23-7.
27. Garrard J, Harms S, Eberly LE, Matiak A. Variations in product choices of frequently purchased herbs: caveat emptor. Arch Intern Med 2003; 163:2290-5.
28. Portoles A, Terleira A, Calvo A, Martinez I, Resplandy G. Effects of Hypericum perforatum on ivabradine pharmacokinetics in healthy volunteers: an open-label, pharmacokinetic interaction clinical trial. J Clin Pharmacol 2006; 46:1188-94.
29. Johne A, Brockmoller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999; 66:338-45.
30. Tian R, Koyabu N, Morimoto S, Shoyama Y, Ohtani H, Sawada Y. Functional induction and de-induction of Pglycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line. Drug Metab Dispos 2005; 33:547-54.
31. McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. CMAJ 1996; 155:293-5.
32. De Smet PAGM. Yohimbe alkaloids-general discussion. In: De Smet PAGM, et al, eds. Adverse Effects of Herbal Drugs. Vol. 3. Berlin: Springer; 1997:181-206.
33. Lacomblez L, et al. Effect of yohimbine on blood pressure in patients with depression and orthostatic hypertension induced by clomipramine. Clin Pharmacol Ther 1989; 45: 241-251.
34. Brinker F. Interactions of pharmaceutical and botanical medicines. J Naturopath Med 1997; 7:14-20.
35. Hammerness P, Basch E, Ulbricht C, Barrette EP, Foppa I, Basch S, et al., for the Natural Standard Research Collaboration. St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics 2003; 44:271-82.
36. Singh YN. Potential for interaction of kava and St. John's wort with drugs. J. Ethnopharmacol 2005; 100:108-13.
37. Izzo AA. Drug interactions with St. John's wort (Hypericum perforatum): a review of the clinical evidence. Int J Clin Pharmacol Ther 2004; 42:139-48.
38. Markowitz JS, DeVane CL. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum). Psychopharmacol Bull 2001; 35:53-64.
39. Roots I. Interaction of an herbal extract from St. John's wort with amitriptyline and its metabolites. Clin Pharmacol Ther 2000; 67:69.
40. Etman M. Effect of a bulk forming laxative on the bioavailablility of carbamazepine in man. Drug Dev Ind Pharm 1995; 21:1901-6.
41. Perlman BB. Interaction between lithium salts and ispaghula husk. Lancet 1990; 335:416.
42. De Smet PAGM, D'Arcy PF. Drug interactions with herbal and other nonorthodox remedies. In: D'Arcy PF, et al, eds. Mechanisms of Drug Interactions. Berlin:Springer-Verlag; 1996.
43. Richter WO, et al. Interaction between fiber and lovastatin. Lancet 1990; 335:416.
44. Stewart DE. High-fiber diet and serum tricylic anti-depressant levels. J Clin Psychopharmacol 1992; 12:438-440.
45. Brown DD, et al. Decreased bioavailability of digoxin due to hypocholesterolemic interventions. Circulation 1978; 58: 164-172.
46. Westendorf J. Anthranoid derivatives-general discussion. In: DeSmet PAGM, et al, eds. Adverse Effects of Herbal Drugs. Vol.2. Berlin: Springer; 1993:105-118.
47. Bever VO, Zahnd GR. Plants with oral hypoglycaemic action. Q J Crude Drug Res 1979; 17:139-196.
48. Yongchaiyudha S, et al. Antidiabetic activity of Aloe vera L. juice. 1. Clinical trial in new cases of diabetes mellitus. Phytomedicine 1996; 3:241-243.
49. Welihinda J, et al. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol 1986; 17:277-282.
50. Leatherdale BA, G et al. Improvement in glucose tolerance due to Momordica charantia (karela). BMJ 1981; 282: 1823-1824.
51. Al-Habori M, Raman A. Antidiabetic and hypocholestrolaemic effects of fenugreek. Phytother Res 1998; 12:233-242.
52. Shanmugasundaram ERB, et al. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus. J Ethnopharmacol 1990; 30:281-294.
53. Baskaran K, et al. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. J Ethnopharmacol 1990; 30: 295-300.
54. Bunyapraphatsara N, et al. Antidiabetic activity of Aloe vera L. juice. II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 1996; 3: 245-248.
55. Sierra M, Garcia JJ, Fernandez N, Diez MJ, Calle AP. Therapeutic effects of psyllium in type 2 diabetic patients. Eur J Clin Nutr 2002; 56:830-42.
56. Ziai SA, Larijani B, Akhoondzadeh S, Fakhrzadeh H, Dastpak A, Bandarian F, et al. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol 2005; 102:202-7.
57. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003; 26:1277-94.
58. Lee LS, Andrade AS, Flexner C. Interactions between natural health products and antiretroviral drugs: pharmacokinetic and pharmacodynamic effects. Clin Infect Dis 2006; 43:1052-9.
59. Gallicano K, Foster B, Choudhri S. Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 2003; 55:199-202.
60. Mills E, Montori V, Perri D, Phillips E, Koren G. Natural health product-HIV drug interactions: a systematic review. Int J STD AIDS 2005; 16:181-6.
61. Van den Bout-van den Beukel CJ, Koopmans PP, van der Ven AJ, De Smet PA,Burger DM. Possible drug-metabolism interactions of medicinal herbs with antiretroviral agents. Drug Metab Rev 2006; 38: 477-514.
62. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-97. JAMA 1998; 280: 1569-75.
63. Barnes J, Mills SY, Abbott NC, et al. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face to face interviews with 515 users of herbal remedies. Br J Clin Pharmacol 1998; 45: 496-500.
64. Westendorf J. Anthranoid derivatives - general discussion. In: De Smet PAGM, Keller K, Hansel R, Chandler RF. Adverse effects of herbal drugs, vol 2: 105-08.
65. Kuhn M. Complementary Therapy-Gram. Vol 4, No.1. Hamburg, NY: Educational Services; April 2001.
66. Smith M. Drug interactions with natural health products/dietary supplements: a survival guide. Paper presented at: Complementary and Alternative Medicine: Implications for Clinical Practice and State-of-the-Science Symposia; March 12, 2000.